{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:52:58Z","timestamp":1791553978137,"version":"4.3.4"},"reference-count":73,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["2202-05781"],"award-info":[{"award-number":["2202-05781"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016872","name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016872","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetes mellitus remains a leading cause of morbidity worldwide, motivating the development of novel diabetes therapeutics. Computational glucoregulatory models that incorporate biochemical signaling and mechanisms have shown utility for preclinical evaluation and even the rational design of such interventions, potentially reducing the need for animal experimentation. In this work, we expand upon our IM3PACT 2.0 computational framework by applying it to human clinical data and demonstrate its utility for translational prediction of glucose-responsive glucagon (GRG) therapeutic performance. The model was parameterized separately for healthy and type 1 diabetes (T1D) humans using a data-fitting procedure applied to clinical insulin and glucagon injection datasets. The resulting healthy model reproduces the damped glucose recovery clinically observed following insulin administration, characteristic of coupled insulin\u2013glucagon regulation. Sensitivity analysis was performed to identify parameters critical to describing glucose responses in the injection datasets, and a species comparison was performed that benchmarked human parameters against our previously validated rat model. Model performance was evaluated using a series of simulated test injections, including doses outside the fitted dataset. This human model was then used to simulate the translational therapeutic effect of a hydrogel-based composite microneedle (cMN) patch GRG, previously evaluated in streptozotocin-induced T1D rats. A generalized parametric GRG design framework was subsequently developed, mapping the kinetic and drug-loading design space that yields effective therapeutic performance in T1D humans. The parameterized framework constitutes a validated in silico platform for the preclinical evaluation and rational design of glucose-responsive glucagon therapeutics in humans.<\/jats:p>","DOI":"10.1021\/acsptsci.6c00356","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:01:28Z","timestamp":1789718488000},"page":"2889-2901","source":"Crossref","is-referenced-by-count":0,"title":["A Human Glucoregulatory\nModel for the Rational Design\nand Evaluation of Diabetes Therapeutics"],"prefix":"10.1021","volume":"9","author":[{"given":"Marco","family":"Machado","sequence":"first","affiliation":[{"name":"Massachusetts Institute of Technology , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3728-9544","authenticated-orcid":true,"given":"Sungyun","family":"Yang","sequence":"additional","affiliation":[{"name":"Massachusetts Institute of Technology , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-5415","authenticated-orcid":true,"given":"Ali A.","family":"Alizadehmojarad","sequence":"additional","affiliation":[{"name":"Massachusetts Institute of Technology , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2944-808X","authenticated-orcid":true,"given":"Michael S.","family":"Strano","sequence":"additional","affiliation":[{"name":"Massachusetts Institute of Technology , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"S6","key":"2026100909100958200_cit1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/dom.16628","article-title":"The Pathophysiology,\nPresentation and Classification\nof Type 1 Diabetes","volume":"27","author":"Aamodt","year":"2025","journal-title":"Diabetes Obes. Metab"},{"issue":"1","key":"2026100909100958200_cit2","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type\n1 Diabetes Mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat.\nRev. Dis. Primers"},{"issue":"19","key":"2026100909100958200_cit3","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.3390\/nu15194279","article-title":"Type 1 and Type 2 Diabetes Mellitus: Commonalities,\nDifferences and the Importance of Exercise and Nutrition","volume":"15","author":"Krause","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"2026100909100958200_cit4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7&lt;539::AID-DIA668&gt;3.0.CO;2-S","article-title":"Definition, Diagnosis and Classification of Diabetes\nMellitus and Its Complications. Part 1: Diagnosis and Classification\nof Diabetes Mellitus. Provisional Report of a WHO Consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"issue":"10","key":"2026100909100958200_cit5","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.2337\/diacare.26.10.2947","article-title":"Diabetes and\nHeart Disease","volume":"26","author":"Barrett-Connor","year":"2003","journal-title":"Diabetes Care"},{"issue":"11","key":"2026100909100958200_cit6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of Diabetes and Diabetes-Related\nComplications","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys. Ther"},{"key":"2026100909100958200_cit7","unstructured":"C. D. C. National Diabetes Statistics Report.\n          \n          National\nDiabetes Statistics Report Diabetes.\n          https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html (Accessed 2024-11-14)."},{"issue":"1","key":"2026100909100958200_cit8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/dci23-0085","article-title":"Economic\nCosts of Diabetes in the\nU.S. in 2022","volume":"47","author":"Parker","year":"2024","journal-title":"Diabetes Care"},{"issue":"10","key":"2026100909100958200_cit9","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.3390\/biomedicines11102852","article-title":"Animal Models in Diabetic Research\u2500History,\nPresence, and Future Perspectives","volume":"11","author":"Pandey","year":"2023","journal-title":"Biomedicines"},{"issue":"25","key":"2026100909100958200_cit10","doi-asserted-by":"publisher","first-page":"2300587","DOI":"10.1002\/adhm.202300587","article-title":"Rational\nDesign and Efficacy of Glucose-Responsive Insulin Therapeutics and\nInsulin Delivery Systems by Computation Using Connected Human and\nRodent Models","volume":"12","author":"Yang","year":"2023","journal-title":"Adv. Healthcare Mater"},{"issue":"22","key":"2026100909100958200_cit11","doi-asserted-by":"publisher","first-page":"1700601","DOI":"10.1002\/adhm.201700601","article-title":"Rational\nDesign of Glucose-Responsive Insulin Using Pharmacokinetic Modeling","volume":"6","author":"Bakh","year":"2017","journal-title":"Adv. Healthcare Mater"},{"issue":"2","key":"2026100909100958200_cit12","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1021\/acs.jmedchem.5c03326","article-title":"ViVo: A Temporal\nModeling Framework That Boosts Statistical Power and Minimizes Animal\nUsage","volume":"69","author":"Canudo-Barreras","year":"2026","journal-title":"J. Med. Chem"},{"issue":"1","key":"2026100909100958200_cit13","doi-asserted-by":"publisher","first-page":"39877","DOI":"10.1038\/srep39877","article-title":"In-Silico\nExperiments of Zebrafish\nBehaviour: Modeling Swimming in Three Dimensions","volume":"7","author":"Mwaffo","year":"2017","journal-title":"Sci. Rep"},{"key":"2026100909100958200_cit14","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1021\/acsptsci.5c00177","article-title":"A Computational\nGlucoregulatory Model of Liver and Glucagon for the Evaluation of\nTherapeutics","volume":"8","author":"Gong","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci"},{"key":"2026100909100958200_cit15","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/S0168-8227(11)70017-1","article-title":"Insulin\nTherapy and Exercise","volume":"93","author":"Kourtoglou","year":"2011","journal-title":"Diabetes Res. Clin. Pract"},{"issue":"2","key":"2026100909100958200_cit16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4161\/isl.24590","article-title":"Clinical Utility\nof Insulin and Insulin Analogs","volume":"5","author":"Sanlioglu","year":"2013","journal-title":"Islets"},{"issue":"6","key":"2026100909100958200_cit17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrd.2015.36","article-title":"Pursuit of a Perfect Insulin","volume":"15","author":"Zaykov","year":"2016","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"2026100909100958200_cit18","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001152","article-title":"Intensive Insulin Therapy\n(Basal-Bolus)","volume":"29","author":"Chico","year":"2022","journal-title":"Am. J. Ther"},{"issue":"4","key":"2026100909100958200_cit19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1503\/cmaj.121265","article-title":"Glucose-Responsive\nInsulin and Glucagon\nDelivery (Dual-Hormone Artificial Pancreas) in Adults with Type 1\nDiabetes: A Randomized Crossover Controlled Trial","volume":"185","author":"Haidar","year":"2013","journal-title":"CMAJ"},{"key":"2026100909100958200_cit20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jcte.2018.12.005","article-title":"Metabolic Effects of Glucagon in\nHumans","volume":"15","author":"Adeva-Andany","year":"2019","journal-title":"J. Clin. Transl. Endocrinol"},{"issue":"9","key":"2026100909100958200_cit21","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/biom11091281","article-title":"Glucagon as a Therapeutic\nApproach\nto Severe Hypoglycemia: After 100 Years, Is It Still the Antidote\nof Insulin?","volume":"11","author":"Porcellati","year":"2021","journal-title":"Biomolecules"},{"key":"2026100909100958200_cit22","article-title":"Hemoglobin\nA1C","volume-title":"StatPearls","author":"Eyth","year":"2024"},{"key":"2026100909100958200_cit23","unstructured":"CGM & Time\nin Range | American Diabetes Association.\n          https:\/\/diabetes.org\/about-diabetes\/devices-technology\/cgm-time-in-range (Accessed 2024-11-15)."},{"issue":"10","key":"2026100909100958200_cit24","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1001\/jama.2015.9536","article-title":"Diabetes:\nAdvances in Diagnosis and Treatment","volume":"314","author":"Nathan","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"2026100909100958200_cit25","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1177\/19322968221105895","article-title":"Retained\nDiabetes Devices\u2500A Literature Review","volume":"17","author":"Xu","year":"2023","journal-title":"J. Diabetes Sci. Technol"},{"issue":"1","key":"2026100909100958200_cit26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-022-05744-z","article-title":"Automated Insulin Delivery: Benefits,\nChallenges, and Recommendations. A Consensus Report of the Joint Diabetes\nTechnology Working Group of the European Association for the Study\nof Diabetes and the American Diabetes Association","volume":"66","author":"Sherr","year":"2023","journal-title":"Diabetologia"},{"issue":"2","key":"2026100909100958200_cit27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/19322968251412442","article-title":"Inpatient Use of Automated Insulin\nDelivery Systems","volume":"20","author":"Chadalawada","year":"2026","journal-title":"J. Diabetes Sci. Technol"},{"issue":"7","key":"2026100909100958200_cit28","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2337\/dbi23-0029","article-title":"Engineering\na Pathway to Glucose-Responsive Therapeutics","volume":"73","author":"Webber","year":"2024","journal-title":"Diabetes"},{"issue":"8035","key":"2026100909100958200_cit29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41586-024-08042-3","article-title":"Glucose-Sensitive Insulin with Attenuation\nof Hypoglycaemia","volume":"634","author":"Hoeg-Jensen","year":"2024","journal-title":"Nature"},{"issue":"28","key":"2026100909100958200_cit30","doi-asserted-by":"publisher","first-page":"2203274","DOI":"10.1002\/advs.202203274","article-title":"Shrinking Fabrication\nof a Glucose-Responsive Glucagon Microneedle\nPatch","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci"},{"issue":"13","key":"2026100909100958200_cit31","doi-asserted-by":"publisher","first-page":"1902004","DOI":"10.1002\/adma.201902004","article-title":"Glucose-Responsive\nInsulin and Delivery Systems: Innovation and Translation","volume":"32","author":"Wang","year":"2020","journal-title":"Adv. Mater"},{"issue":"2","key":"2026100909100958200_cit32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/acsmaterialsau.4c00138","article-title":"Glucose-Responsive\nMaterials for Smart Insulin Delivery: From Protein-Based to Protein-Free\nDesign","volume":"5","author":"Pal","year":"2025","journal-title":"ACS Mater. Au"},{"issue":"2","key":"2026100909100958200_cit33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/cpt.1215","article-title":"Clinical Evaluation of MK-2640: An\nInsulin Analog With Glucose-Responsive Properties","volume":"105","author":"Krug","year":"2019","journal-title":"Clin. Pharmacol. Ther"},{"issue":"6","key":"2026100909100958200_cit34","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/cpt.1729","article-title":"A Model-Informed\nDrug Discovery and Development Strategy for the Novel Glucose-Responsive\nInsulin MK-2640 Enabled Rapid Decision Making","volume":"107","author":"Visser","year":"2020","journal-title":"Clin. Pharmacol. Ther"},{"issue":"10","key":"2026100909100958200_cit35","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1021\/acsptsci.3c00095","article-title":"In Silico\nInvestigation of the Clinical Translatability of Competitive Clearance\nGlucose-Responsive Insulins","volume":"6","author":"Yang","year":"2023","journal-title":"ACS Pharmacol.\nTransl. Sci"},{"issue":"2","key":"2026100909100958200_cit36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cbi.2006.12.006","article-title":"Computer-Aided\nDrug Discovery and Development (CADDD): In Silico-Chemico-Biological\nApproach","volume":"171","author":"Kapetanovic","year":"2008","journal-title":"Chem. Biol. Interact"},{"issue":"3","key":"2026100909100958200_cit37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/pharmaceutics16030332","article-title":"Advancing Precision Medicine: A Review\nof Innovative In Silico Approaches for Drug Development, Clinical\nPharmacology and Personalized Healthcare","volume":"16","author":"Marques","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"2026100909100958200_cit38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1932296813514502","article-title":"The UVA\/PADOVA Type\n1 Diabetes Simulator","volume":"8","author":"Man","year":"2014","journal-title":"J. Diabetes Sci. Technol"},{"issue":"2","key":"2026100909100958200_cit39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1932296818757747","article-title":"The UVA\/Padova Type 1 Diabetes Simulator\nGoes From Single Meal to Single Day","volume":"12","author":"Visentin","year":"2018","journal-title":"J. Diabetes\nSci. Technol"},{"issue":"10","key":"2026100909100958200_cit40","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1109\/TBME.2007.893506","article-title":"Meal Simulation Model of the Glucose-Insulin\nSystem","volume":"54","author":"Dalla Man","year":"2007","journal-title":"IEEE Trans. Biomed. Eng"},{"issue":"4","key":"2026100909100958200_cit41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1088\/0967-3334\/25\/4\/010","article-title":"Nonlinear Model Predictive Control\nof Glucose Concentration in Subjects with Type 1 Diabetes","volume":"25","author":"Hovorka","year":"2004","journal-title":"Physiol. Meas"},{"key":"2026100909100958200_cit42","unstructured":"Sorensen, J. T.\n          \n          A Physiologic Model\nof Glucose Metabolism in Man and Its Use to Design and Assess Improved\nInsulin Therapies for Diabetes. Thesis, Massachusetts Institute of\nTechnology, 1985. https:\/\/dspace.mit.edu\/handle\/1721.1\/15234 (Accessed 2024-11-27)."},{"issue":"1","key":"2026100909100958200_cit43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/adhm.201400264","article-title":"A Pharmacokinetic\nModel of a Tissue Implantable Insulin Sensor","volume":"4","author":"Bisker","year":"2015","journal-title":"Adv. Healthcare Mater"},{"issue":"8","key":"2026100909100958200_cit44","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.2337\/db19-0879","article-title":"Connecting Rodent\nand Human Pharmacokinetic Models for the Design and Translation of\nGlucose-Responsive Insulin","volume":"69","author":"Yang","year":"2020","journal-title":"Diabetes"},{"issue":"4","key":"2026100909100958200_cit45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10928-011-9200-x","article-title":"Development\nof Appropriate Equations for Physiologically\nBased Pharmacokinetic Modeling of Permeability-Limited and Flow-Limited\nTransport","volume":"38","author":"Thompson","year":"2011","journal-title":"J. Pharmacokinet. Pharmacodyn"},{"key":"2026100909100958200_cit46","unstructured":"The MathWorks, Inc.\n          \n          MATLAB, 2025. https:\/\/www.mathworks.com\/products\/matlab.html."},{"issue":"10","key":"2026100909100958200_cit47","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1021\/js99007p","article-title":"Pharmacokinetic\nand Glucodynamic Comparisons of Recombinant and Animal-Source\nGlucagon after IV, IM, and SC Injection in Healthy Volunteers","volume":"88","author":"Graf","year":"1999","journal-title":"J. Pharm. Sci"},{"issue":"3","key":"2026100909100958200_cit48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/dom.13562","article-title":"Low Doses of Dasiglucagon\nConsistently Increase Plasma Glucose Levels\nfrom Hypoglycaemia and Euglycaemia in People with Type 1 Diabetes\nMellitus","volume":"21","author":"Ho\u0308velmann","year":"2019","journal-title":"Diabetes Obes. Metab"},{"issue":"7","key":"2026100909100958200_cit49","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/BF00417697","article-title":"Pharmacokinetics, Pharmacodynamics\nand Glucose Counterregulation Following Subcutaneous Injection of\nthe Monomeric Insulin Analogue [Lys(B28),Pro(B29)] in IDDM","volume":"37","author":"Torlone","year":"1994","journal-title":"Diabetologia"},{"issue":"1","key":"2026100909100958200_cit50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s005920070034","article-title":"Improved Postprandial\nGlycaemic Controls with Insulin Aspart in Type 2 Diabetic Patients\nTreated with Insulin","volume":"37","author":"Rosenfalck","year":"2000","journal-title":"Acta Diabetol"},{"issue":"3","key":"2026100909100958200_cit51","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/dc17-1402","article-title":"Pharmacokinetic and\nPharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and\nStable Glucagon Analog","volume":"41","author":"Ho\u0308velmann","year":"2018","journal-title":"Diabetes Care"},{"key":"2026100909100958200_cit52","first-page":"1","article-title":"Diabetes:\nMechanism, Pathophysiology and Management-A Review","volume":"5","author":"Siddiqui","year":"2013","journal-title":"Gestational Diabetes"},{"key":"2026100909100958200_cit53","unstructured":"MATLAB.\n          \n          particleswarm - Particle swarm optimization\n          https:\/\/www.mathworks.com\/help\/gads\/particleswarm.html (Accessed\n2026-07-30)."},{"key":"2026100909100958200_cit54","unstructured":"MATLAB.\n          \n          patternsearch - Find minimum of function\nusing pattern search\n          https:\/\/www.mathworks.com\/help\/gads\/patternsearch.html (Accessed 2026-07-30)."},{"issue":"4","key":"2026100909100958200_cit55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11538-024-01274-4","article-title":"Nonlinear\nRegression Modelling: A Primer with Applications\nand Caveats","volume":"86","author":"O\u2019brien","year":"2024","journal-title":"Bull. Math. Biol"},{"issue":"30","key":"2026100909100958200_cit56","doi-asserted-by":"publisher","first-page":"1901051","DOI":"10.1002\/adma.201901051","article-title":"Glucose-Responsive\nComposite Microneedle Patch for Hypoglycemia-Triggered\nDelivery of Native Glucagon","volume":"31","author":"GhavamiNejad","year":"2019","journal-title":"Adv. Mater"},{"issue":"29","key":"2026100909100958200_cit57","doi-asserted-by":"publisher","first-page":"2401410","DOI":"10.1002\/adhm.202401410","article-title":"Analysis of Glucose\nResponsive Glucagon Therapeutics Using Computational Models of the\nGlucoregulatory System","volume":"13","author":"Alizadehmojarad","year":"2024","journal-title":"Adv. Healthcare Mater"},{"issue":"3","key":"2026100909100958200_cit58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bpj.2017.11.3780","article-title":"Steady-State Differential\nDose Response in Biological\nSystems","volume":"114","author":"Yordanov","year":"2018","journal-title":"Biophys. J"},{"issue":"2","key":"2026100909100958200_cit59","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1978.235.2.E97","article-title":"Simultaneous\nAnalysis of Families\nof Sigmoidal Curves: Application to Bioassay, Radioligand Assay, and\nPhysiological Dose-Response Curves","volume":"235","author":"DeLean","year":"1978","journal-title":"Am. J. Physiol.\n- Endocrinol. Metab"},{"issue":"5","key":"2026100909100958200_cit60","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2337\/diacare.28.5.1245","article-title":"Defining and Reporting Hypoglycemia in Diabetes:\nA Report from the\nAmerican Diabetes Association Workgroup on Hypoglycemia","volume":"28","author":"American Diabetes Association Workgroup on Hypoglycemia.","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"2026100909100958200_cit61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jdiacomp.2014.09.001","article-title":"Factors Affecting\nthe Success of Glucagon Delivered during an Automated Closed-Loop\nSystem in Type 1 Diabetes","volume":"29","author":"Bakhtiani","year":"2015","journal-title":"J. Diabetes Complicat"},{"key":"2026100909100958200_cit62","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.2147\/DMSO.S554306","article-title":"Comparative Evaluation\nof Responsiveness of Insulin Counter-Regulatory Hormones and Insulin\nResistance to Hypoglycemia in Newly Diagnosed Type 1 Diabetes Mellitus\nMan","volume":"18","author":"Zhou","year":"2025","journal-title":"Diabetes Metab. Syndr. Obes.: Targets Ther"},{"issue":"2","key":"2026100909100958200_cit63","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1993.264.2.E149","article-title":"Glucose\nCounterregulation: Prevention and Correction of Hypoglycemia in Humans","volume":"264","author":"Cryer","year":"1993","journal-title":"Am. J. Physiol. - Endocrinol. Metab"},{"issue":"16","key":"2026100909100958200_cit64","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15009","article-title":"Mini-review: Glucagon Responses in\nType 1 Diabetes \u2013 a Matter of Complexity","volume":"9","author":"Bisgaard Bengtsen","year":"2021","journal-title":"Physiol. Rep"},{"issue":"2","key":"2026100909100958200_cit65","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2337\/diab.40.2.263","article-title":"Role of Glucose,\nInsulin, and Glucagon in Glycogen Mobilization in Human Hepatocytes","volume":"40","author":"Lo\u0301pez","year":"1991","journal-title":"Diabetes"},{"key":"2026100909100958200_cit66","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mam.2015.09.002","article-title":"Role of Glycogen\nPhosphorylase in Liver Glycogen Metabolism","volume":"46","author":"Agius","year":"2015","journal-title":"Mol. Asp. Med"},{"issue":"1","key":"2026100909100958200_cit67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.13435","article-title":"Insulin Regulation\nof Gluconeogenesis","volume":"1411","author":"Hatting","year":"2018","journal-title":"Ann. N. Y. Acad. Sci"},{"issue":"3","key":"2026100909100958200_cit68","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The Use\nof Animal Models in Diabetes Research","volume":"166","author":"King","year":"2012","journal-title":"British\nJ Pharmacology"},{"issue":"4","key":"2026100909100958200_cit69","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1464-5491.2005.01499.x","article-title":"Animal Models of\nDiabetes Mellitus","volume":"22","author":"Rees","year":"2005","journal-title":"Diabetic Medicine"},{"key":"2026100909100958200_cit70","doi-asserted-by":"publisher","first-page":"1359685","DOI":"10.3389\/fendo.2024.1359685","article-title":"Animal Models for Type 1 and Type\n2 Diabetes: Advantages and Limitations","volume":"15","author":"Singh","year":"2024","journal-title":"Front.\nEndocrinol"},{"issue":"32","key":"2026100909100958200_cit71","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1021\/jacs.1c04570","article-title":"Glucose-Fueled\nPeptide Assembly: Glucagon Delivery via Enzymatic Actuation","volume":"143","author":"Yu","year":"2021","journal-title":"J. Am. Chem. Soc"},{"issue":"11","key":"2026100909100958200_cit72","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1021\/acscentsci.4c00937","article-title":"A Glucose-Responsive\nGlucagon-Micelle for the Prevention of Hypoglycemia","volume":"10","author":"Vinciguerra","year":"2024","journal-title":"ACS Cent. Sci"},{"issue":"3","key":"2026100909100958200_cit73","doi-asserted-by":"publisher","DOI":"10.1002\/smsc.202500555","article-title":"Engineering\na Glucose-Responsive\nGlucagon Prodrug Through Arginine\u2013Phenylboronic Acid Pendant\nModification","volume":"6","author":"DeWolf","year":"2026","journal-title":"Small Sci"}],"container-title":["ACS Pharmacology &amp; Translational\nScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsptsci.6c00356","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aptsfn\/article-pdf\/9\/10\/2889\/68552252\/acsptsci.6c00356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aptsfn\/article-pdf\/9\/10\/2889\/68552252\/acsptsci.6c00356.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:31:42Z","timestamp":1791552702000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aptsfn\/article\/9\/10\/2889\/5432500\/A-Human-Glucoregulatory-Model-for-the-Rational"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":73,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,18]]},"published-print":{"date-parts":[[2026,10,9]]}},"URL":"https:\/\/doi.org\/10.1021\/acsptsci.6c00356","relation":{},"ISSN":["2575-9108"],"issn-type":[{"value":"2575-9108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}